About JenaValve Technology
JenaValve Technology is a company based in Irvine (United States) founded in 2006 was acquired by Edwards Lifesciences in July 2024. JenaValve Technology has raised $363.7 million across 13 funding rounds from investors including Peijia Medical Technologies, Edwards Lifesciences and Edmond de Rothschild. The company has 198 employees as of December 31, 2023. JenaValve Technology offers products and services including Trilogy System and ALIGN-AR Study. JenaValve Technology operates in a competitive market with competitors including Shockwave Medical, Venus MedTech, Cardiac Dimensions, Pi-Cardia and Peijia Medical Technologies, among others.
- Headquarter Irvine, United States
- Employees 198 as on 31 Dec, 2023
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$363.7 M (USD)
in 13 rounds
-
Latest Funding Round
$100 M (USD), Series C
Dec 21, 2021
-
Investors
Peijia Medical Technologies
& 18 more
-
Employee Count
198
as on Dec 31, 2023
-
Acquired by
Edwards Lifesciences
(Jul 25, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of JenaValve Technology
JenaValve Technology offers a comprehensive portfolio of products and services, including Trilogy System and ALIGN-AR Study.
Device for treating severe aortic regurgitation in high-risk patients.
Research evaluating safety and efficacy of Trilogy System.
People of JenaValve Technology
Unlock access to complete
Unlock access to complete
Leadership Team
17 people
Software Development Team
13 people
Product Management Team
5 people
Operations Team
5 people
Senior Team
5 people
Principal Team
4 people
Sales and Marketing
3 people
Human Resources and Administration
3 people
Unlock access to complete
Funding Insights of JenaValve Technology
JenaValve Technology has successfully raised a total of $363.7M across 13 strategic funding rounds. The most recent funding activity was a Series C round of $100 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in JenaValve Technology
JenaValve Technology has secured backing from 19 investors, including venture fund and institutional investors. Prominent investors backing the company include Peijia Medical Technologies, Edwards Lifesciences and Edmond de Rothschild.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on pharmaceutical, biotechnology, and medical sectors.
|
Locked | Locked | Locked | |
|
Capital is provided to firms for growth, buyouts, and acquisitions.
|
Locked | Locked | Locked | |
|
Venture capital fund focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for JenaValve Technology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by JenaValve Technology
Investment portfolio details for JenaValve Technology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - JenaValve Technology
Detailed financials for JenaValve Technology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Jenavalve Technology Comparisons
Peer comparison for JenaValve Technology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of JenaValve Technology
JenaValve Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Shockwave Medical, Venus MedTech, Cardiac Dimensions, Pi-Cardia and Peijia Medical Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed.
|
|
| Locked | Locked | Locked |
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures.
|
|
| Locked | Locked | Locked |
Invasive cardiac implants for heart failure treatment are developed.
|
|
| Locked | Locked | Locked |
Non-implant devices for cardiac valve repair are developed and manufactured.
|
|
| Locked | Locked | Locked |
Medical devices for cardiac and cerebrovascular treatments are developed.
|
|
| Locked | Locked | Locked |
Smart medical devices for heart valve diseases are developed.
|
Detailed competitors of JenaValve Technology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Jenavalve Technology
Complete news archive for JenaValve Technology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about JenaValve Technology
JenaValve Technology was founded in 2006.
JenaValve Technology is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
John Kilcoyne is the current CEO of JenaValve Technology.
JenaValve Technology is a funded company, having raised a total of $363.7M across 13 funding rounds to date.
As of Dec 31, 2023, the latest employee count at JenaValve Technology is 198.
Provider of pericardial transcatheter aortic valve replacement and delivery system. It offers Trilogy Valve with locator technology that includes a root valve sewn onto a stent and a delivery system for the treatment of aortic valve stenosis for treatment of patients suffering from the aortic valve insufficiency.
JenaValve Technology's top competitors include Shockwave Medical, Cardiac Dimensions and Peijia Medical Technologies.
JenaValve Technology offers Trilogy System and ALIGN-AR Study.
JenaValve Technology has 19 investors. Key investors include Peijia Medical Technologies, Edwards Lifesciences, Edmond de Rothschild, Gimv, and Andera Partners.